Welcome to our blog

Our blog is a space for healthcare professionals to freely share and discuss their opinions and experiences. Please contact us if you’d like to contribute.

WHAT'S ON THE HORIZON?

Opinion & insight from our Clinical Steering Group

Horizons, led by a team of experts from our Clinical Steering Group, is a series of scientific articles which take a deep dive into the emerging trends in the healthcare landscape, kickstarting a dialogue about how treatments and strategies should be best implemented for the benefit of patients. Click below to find out more.

What's on the horizon?

Penny Staton

Improving non-alcoholic steatohepatitis care – is the finishing line in sight?

Posted 25 days ago

An intense race is going on right now in non-alcoholic steatohepatitis (NASH) research. A number of significant players within the pharmaceutical and biotechnology sectors are competing to develop the first major therapeutic advance in treatment for this neglected condition. But should we consider it more of a relay race? Could improved diagnosis, disease assessment and even combination therapy be the key to victory over this increasingly prevalent disease?

Marshall Pearce

Left ventricular assist devices – A viable therapeutic option for heart failure?

Posted 4 months ago

Alongside a pharmacological strategy to aid myocardial recovery, LVADs may prove to have a significant role to play in the ever-growing problem of heart failure. Although LVADs are not new onto the scene, the advance of technology – smaller, more efficient devices with better reliability and potentially transcutaneous power transfer – means we may be on the cusp of seeing many more deployed to tackle heart failure.

Marshall Pearce

Cancer immunotherapies

Posted 6 months ago

It was the winner of the 1908 Nobel prize for medicine, Paul Ehrlich, who is first credited with discussing the concept of a “magic bullet”, able to target specific cells without damaging healthy tissue. With the advent of immunotherapy, as well as antibody-drug conjugates, we are beginning to realise this vision.

Marshall Pearce

Antibody-drug conjugates (ADCs)

Posted 6 months ago

Over the past couple of decades, there have been advances in a class of drugs which for a long time was purely theoretical: antibody-drug conjugates (ADCs). The concept underlying ADCs is elegant – what if it were possible to ‘target’ particular groups of cells with a cytotoxic agent, rather than exposing every cell of the body to it?

Recent Posts

Lauren McCracken

Transforming Lives Through Technology: Diabetes

Posted 3 months ago

Right now, with a swipe or tap, I can tell you how many calories I’ve consumed, how far I’ve walked and how well I slept last night. However, digital health technology and its analytics have mixed reviews from the general public, some become obsessed wanting to know every macronutrient that goes into their body and others see it as just another gimmick. But what about those with chronic conditions like diabetes?

Professor Gerhard Pölzl

Acute and Advanced Heart Failure: new data, new studies, new opinions, new trends.

Posted 3 months ago

Professor Gerhard Pölzl focuses on the therapeutic options for acute and advanced heart failure.

Christopher Paul Jones

Dealing with mental health issues using integrated approaches, including tech and apps

Posted 3 months ago

As healthcare professionals are well aware, a significant percentage of the population (approximately one in four) will suffer a mental health problem at some point in their lives. In the course of his work, Christopher Paul Jones is finding that people are increasingly looking for alternatives to, or approaches to complement, pharmaceutical drugs to manage their conditions, and that tech and apps are proving very useful indeed. He feels it is particularly useful for those whose location or financial status might otherwise prohibit them from integrated strategies. Here is what he has to say:

Dr Elizabeth Angier

What’s Allergy got to do with it?

Posted 4 months ago

Experiences of an allergy and immunology congress - a short blog (by a primary care physician).

Fiona Holland

What to say and do when someone has cancer

Posted 8 months ago

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.

Liam Farrell

Bad smells are good

Posted 1 year ago

Delicacy is not a virtue in this job.

epgonline.org team

From Feedback to Feature: the evolution of epgonline.org

Posted 1 year ago

Our free and independent website for healthcare professionals (HCPs) worldwide has been redeveloped thanks to valuable input from you: our epgonline.org community and survey takers. Find out about key new features here.

Monica Caliber

Hypogonadism – why important to diagnose and treat?

Posted 1 year ago

Most clinicians and patients think that the purpose of treating hypogonadism is to merely relieve symptoms. However, this only scratches the surface... 

Liam Farrell

One title is enough

Posted 1 year ago

Titles are scarce in this Republican heartland...

Heather Lander, PhD

Zika Virus: old lessons from a newly emerging pathogen

Posted 1 year ago

Virologist-turned-Science Writer, Dr. Heather Lander, discusses the emergence of Zika virus and what we know so far.

More posts

Dr Elizabeth Angier

What’s Allergy got to do with it?

Posted 4 months ago

Experiences of an allergy and immunology congress - a short blog (by a primary care physician).

Am Ang Zhang

Autism: Frances Tustin and Entrenchment!

Posted 1 year ago

Am Ang Zhang discusses his work with pioneering child psychotherapist Frances Tustin, and his observations of entrenchment in autistic children.

Robin Hewings

Diabetes Patients Must Be Better Educated About Their Condition

Posted 1 year ago

Not everyone is convinced that education courses help people look after their diabetes. And the GP I was chatting to a couple of months ago was one of them. He wasn’t sure they worked. People didn’t seem that interested and he wasn’t really sure what people would learn anyway.

Alastair Miller

What is Tropical Medicine?

Posted 1 year ago

At first sight this seems a question with an obvious response and not one that requires much debate in this blog. However, the answer may be more complex than it initially appears and may benefit from further exploration.

Hugh Harvey

Metrics Madness

Posted 2 years ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

David Warriner

What is Overdiagnosis?

Posted 2 years ago

Overdiagnosis is the diagnosis of disease that will cause neither morbidity nor mortality during a patient’s lifetime. Doctors are trained to listen, examine, test, diagnose and treat patients, but we are not warned of the possible dangers of “diseases”, the diagnosis of which will not benefit the patient and may also lead to harm. I would argue that the Hippocratic oath, in particular “Primum non nocere” (first, do no harm) should be at the forefront of every clinician’s mind when seeing patients.

Blog archive